Cardlytics Stock Investor Sentiment
| CDLX Stock | USD 0.94 0.03 3.09% |
Slightly above 56% of Cardlytics' investor base is looking to short. The current sentiment regarding investing in Cardlytics stock implies that many traders are alarmed. Cardlytics' investing sentiment can be driven by a variety of factors including economic data, Cardlytics' earnings reports, geopolitical events, and overall market trends.
Cardlytics | Build AI portfolio with Cardlytics Stock |
Cardlytics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Cardlytics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors may consider stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to consider selling stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Cardlytics Maximum Pain Price Across April 17th 2026 Option Contracts
Cardlytics' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Cardlytics close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Cardlytics' options.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Cardlytics' Stock prices. Below is the latest headlines and news related to Cardlytics Stock. Current markets are slightly bearish. About 55% of major world exchanges and indexes are down. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Cardlytics that are available to investors today. This information is accessible both publicly - through Cardlytics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Cardlytics-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Cardlytics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cardlytics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cardlytics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cardlytics alpha.
Cardlytics Largest EPS Surprises
Earnings surprises can significantly impact Cardlytics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-07 | 2024-06-30 | -0.13 | -0.15 | -0.02 | 15 | ||
2024-05-08 | 2024-03-31 | -0.11 | -0.09 | 0.02 | 18 | ||
2024-03-14 | 2023-12-31 | 0.12 | 0.14 | 0.02 | 16 | ||
2023-11-08 | 2023-09-30 | -0.01 | 0.01 | 0.02 | 200 | ||
2021-03-01 | 2020-12-31 | -0.03 | -0.05 | -0.02 | 66 | ||
2020-05-11 | 2020-03-31 | -0.21 | -0.26 | -0.05 | 23 |
There is far too much social signal, news, headlines, and media speculation about Cardlytics that are available to investors today. This information is accessible both publicly - through Cardlytics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Cardlytics-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Cardlytics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Cardlytics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Cardlytics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Cardlytics alpha.
Cardlytics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Cardlytics Q3 2025 Earnings Call Transcript | 11/06/2025 |
2 | Why Cardlytics Inc. stock trades below fair value - Market Risk Report Real-Time Buy Signal Alerts - newser.com | 11/13/2025 |
3 | How Cardlytics Inc. stock trades in high volatility - 2025 Trade Ideas AI Powered Market Entry Strategies - newser.com | 11/19/2025 |
4 | Cardlytics CFO Alexis DeSieno Announces Resignation - TipRanks | 12/05/2025 |
5 | Cardlytics Trading Up 4.9 percent Should You Buy | 12/24/2025 |
6 | Disposition of 14349 shares by Alexis DeSieno of Cardlytics subject to Rule 16b-3 | 12/31/2025 |
7 | Cardlytics Upgraded to Buy Heres What You Should Know | 01/05/2026 |
8 | Acquisition by David Evans of 1000000 shares of Cardlytics subject to Rule 16b-3 | 01/12/2026 |
9 | Analysts Conflicted on These Communication Services Names Cardlytics and Meta Platforms - The Globe and Mail | 01/27/2026 |
Additional Tools for Cardlytics Stock Analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.





